Signal transduction mediated through adhesion-GPCRs

Advances in Experimental Medicine and Biology

Volumn 706, Issue , 2010, Pages 157-166

  Mizuno, Norikazu ^b   Itoh, Hiroshi ^a  

^a NARA INSTITUTE OF SCIENCE AND TECHNOLOGY   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 56; MEMBRANE PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG;

4 AMINOBUTYRIC ACID RELEASE; ADHESION; ANTIBODY PRODUCTION; ARTICLE; BINDING AFFINITY; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CELL PROLIFERATION; DIMERIZATION; GENE OVEREXPRESSION; GENETIC VARIABILITY; GLYCOSYLATION; HUMAN; IMMUNOPRECIPITATION; NEUROTRANSMISSION; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CLEAVAGE; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; RNA SPLICING; SIGNAL TRANSDUCTION;

ANIMALS; ANTIBODIES; PROTEIN CONFORMATION; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION;

EID: 79960800882     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-7913-1_14     Document Type: Article

References (52)

1. Yona S, Lin HH, Siu WO et al. Adhesion-GPCRs: Emerging roles for novel receptors. Trends Biochem Sci 2008; 33:491-500.
2. Lagerstrom MC, Schioth HB. Structural diversity of G protein-coupled receptors and significance for drug discovery. Nat Rev Drug Discov 2008; 7:339-357.
3. Stacey M, Chang GW, Davies JQ et al. The epidermal growth factor-like domains of the human EMR2 receptor mediate cell attachment through chondroitin sulfate glycosaminoglycans. Blood 2003; 102:2916-2924. (Pubitemid 37248865)
4. Stacey M, Lin HH, Hilyard KL et al. Human epidermal growth factor (EGF) module-containing mucin-like hormone receptor 3 is a new member of the EGF-TM7 family that recognizes a ligand on human macrophages and activated neutrophils. J Biol Chem 2001; 276:18863-18870.
5. Stacey M, Chang GW, Sanos SL et al. EMR4, a novel epidermal growth factor (EGF)-TM7 molecule up-regulated in activated mouse macrophages, binds to a putative cellular ligand on B lymphoma cell line A20. J Biol Chem 2002; 277:29283-29293.
6. Hamann J, Vogel B, van Schijndel GM et al. The seven-span transmembrane receptor CD97 has a cellular ligand (CD55, DAF). J Exp Med 1996; 184:1185-1189. (Pubitemid 26313577)
7. Hamann J, Stortelers C, Kiss-Toth E et al. Characterization of the CD55 (DAF)-binding site on the seven-span transmembrane receptor CD97. Eur J Immunol 1998; 28:1701-1707. (Pubitemid 28221175)
8. Lin HH, Stacey M, Saxby C et al. Molecular analysis of the epidermal growth factor-like short consensus repeat domain-mediated protein-protein interactions: Dissection of the CD97-CD55 complex. J Biol Chem 2001; 276:24160-24169.
9. Abbott RJ, Spendlove I, Roversi P et al. Structural and functional characterization of a novel T-cell receptor coregulatory protein complex, CD97-CD55. J Biol Chem 2007; 282:22023-22032. (Pubitemid 47195739)
10. Xu L, Begum S, Hearn JD et al. GPR56, an atypical G protein-coupled receptor, binds tissue transglutaminase, TG2 and inhibits melanoma tumor growth and metastasis. Proc Natl Acad Sci USA 2006; 103:9023-9028. (Pubitemid 43902526)
11. Davletov BA, Shamotienko OG, Lelianova VG et al. Isolation and biochemical characterization of a Ca2*-independent a-latrotoxin-binding protein. J Biol Chem 1996; 271:23239-23245. (Pubitemid 26314764)
12. Willson J, Amliwala K, Davis A et al. Latrotoxin receptor signaling engages the UNC-13-dependent vesicle-priming pathway in C. elegans. Curr Biol 2004; 14:1374-1379. (Pubitemid 39081640)
13. Park D, Tosello-Trampont AC, Elliott MR et al. BAI1 is an engulfment receptor for apoptotic cells upstream of the ELMO/Dock180/Rac module. Nature 2007; 450:430-434. (Pubitemid 350126756)
14. Nishimori H, Shiratsuchi T, Urano T et al. A novel brain-specific p53-target gene, BAH, containing thrombospondin type 1 repeats inhibits experimental angiogenesis. Oncogene 1997; 15:2145-2150. (Pubitemid 27493903)
15. Koh JT, Kook H, Kee HJ et al. Extracellular fragment of brain-specific angiogenesis inhibitor 1 suppresses endothelial cell proliferation by blocking av|35 integrin. Exp Cell Res 2004; 294:172-184. (Pubitemid 38232664)
16. Silva JP, Lelianova V, Hopkins C et al. Functional cross-interaction of the fragments produced by the cleavage of distinct adhesion G-protein-coupled receptors. J Biol Chem 2009; 284:6495-506.
17. Kwakkenbos MJ, Kop EN, Stacey M et al. The EGF-TM7 family: A postgenomic view. Immunogenetics 2004; 55:655-666. (Pubitemid 38221665)
18. Davletov BA, Meunier FA, Ashton AC et al. Vesicle exocytosis stimulated by alpha-latrotoxin is mediated by latrophilin and requires both external and stored Ca2*. EMBO J 1998; 17:3909-3920. (Pubitemid 28333977)
19. Ashton AC, Volynski KE, Lelianova VG et al. a-Latrotoxin, acting via two Ca2*-dependent pathways, triggers exocytosis of two pools of synaptic vesicles. J Biol Chem 2001; 276:44695-44703.
20. Capogna M, Volynski KE, Emptage NJ et al. The a-latrotoxin mutant LTXN4C enhances spontaneous and evoked transmitter release in CA3 pyramidal neurons. J Neurosci 2003; 23:4044-4053. (Pubitemid 36958423)
21. Lelianova VG, Davletov BA, Sterling A et al. a-latrotoxin receptor, latrophilin, is a novel member of the secretin family of G protein-coupled receptors. J Biol Chem 1997; 272:21504-21508. (Pubitemid 27374024)
22. Rahman MA, Ashton AC, Meunier FA et al. Norepinephrine exocytosis stimulated by a-latrotoxin requires both external and stored Ca2* and is mediated by latrophilin, G proteins and phospholipase C. Philos Trans R Soc Lond B Biol Sci 1999; 354:379-386. (Pubitemid 29365612)
23. Iguchi T, Sakata K, Yoshizaki K et al. Orphan G protein-coupled receptor GPR56 regulates neural progenitor cell migration via a Ga12/13 and Rho pathway. J Biol Chem 2008; 283:14469-14478.
24. Piao X, Hill RS, Bodell A et al. G protein-coupled receptor-dependent development of human frontal cortex. Science 2004; 303:2033-2036. (Pubitemid 38393281)
25. Jin Z, Tietjen I, Bu L et al. Disease-associated mutations affect GPR56 protein trafficking and cell surface expression. Hum Mol Genet 2007; 16:1972-1985. (Pubitemid 47354880)
26. Shashidhar S, Lorente G, Nagavarapu U et al. GPR56 is a GPCR that is overexpressed in gliomas and functions in tumor cell adhesion. Oncogene 2005; 24:1673-1682. (Pubitemid 40461124)
27. Ke N, Sundaram R, Liu G et al. Orphan G protein-coupled receptor GPR56 plays a role in cell transformation and tumorigenesis involving the cell adhesion pathway. Mol Cancer Ther 2007; 6:1840-1850. (Pubitemid 46954061)
28. Seifert, R, Wenzel-Seifert K. Constitutive activity of G-protein-coupled receptors: Cause of disease and common property of wild-type receptors. Naunyn Schmiedebergs Arch Pharmacol 2002; 366:381-416. (Pubitemid 35251788)
29. Rosenbaum DM, Rasmussen SG, Kobilka BK. The structure and function of G-protein-coupled receptors. Nature 2009; 459:356-363.
30. Levoye A, Dam J, Ayoub MA et al. Do orphan G-protein-coupled receptors have ligand-independent functions? New insights from receptor heterodimers. EMBO Rep 2006; 7:1094-1098. (Pubitemid 44660563)
31. Davies JQ, Chang GW, Yona S et al. The role of receptor oligomerization in modulating the expression and function of leukocyte adhesion-G protein-coupled receptors. J Biol Chem 2007; 282:27343-27353. (Pubitemid 47501907)
32. Kim JE, Han JM, Park CR et al. Splicing variants of the orphan G-protein-coupled receptor GPR56 regulate the activity of transcription factors associated with tumorigenesis. J Cancer Res Clin Oncol 2010; 136:47-53.
33. Shi CS, Sinnarajah S, Cho H et al. G13a-mediated PYK2 activation. PYK2 is a mediator of G13a -induced serum response element-dependent transcription. J Biol Chem 2000; 275:24470-24476. (Pubitemid 30626539)
34. Koch WJ, Hawes BE, Inglese J et al. Cellular expression of the carboxyl terminus of a G protein-coupled receptor kinase attenuates Gpy-mediated signaling. J Biol Chem 1994; 269:6193-6197.
35. Katada T, Ui M. Direct modification of the membrane adenylate cyclase system by islet-activating protein due to ADP-ribosylation of a membrane protein. Proc Natl Acad Sci USA 1982; 79:3129-3133.
36. Kurose H, Katada T, Amano T et al. Specific uncoupling by islet-activating protein, pertussis toxin, of negative signal transduction via a-adrenergic, cholinergic and opiate receptors in neuroblastoma x glioma hybrid cells. J Biol Chem 1983; 258:4870-4875. (Pubitemid 13096378)
37. TakasakiJ,SaitoT,TaniguchiMetal.AnovelGaq/ll-selective inhibitor. JBiolChem2004; 279:47438-47445.
38. Magnusson Y, Wallukat G, Waagstein F et al. Autoimmunity in idiopathic dilated cardiomyopathy. Characterization of antibodies against the p 1-adrenoceptor with positive chronotropic effect. Circulation 1994; 89:2760-2767. (Pubitemid 24173697)
39. Elies R, Fu LX, Eftekhari P et al. Immunochemical and functional characterization of an agonist-like monoclonal antibody against the M2 acetylcholine receptor. Eur J Biochem 1998; 251:659-666. (Pubitemid 28108959)
40. Peter JC, Wallukat G, Tugler J et al. Modulation of the M2 muscarinic acetylcholine receptor activity with monoclonal anti-M2 receptor antibody fragments. J Biol Chem 2004; 279:55697-55706. (Pubitemid 40066575)
41. Lebesgue D, Wallukat G, Mijares A et al. An agonist-like monoclonal antibody against the human p2-adrenoceptor. Eur J Pharmacol 1998; 348:123-133. (Pubitemid 28266761)
42. Rees Smith B, McLachlan SM, Furmaniak J. Autoantibodies to the thyrotropin receptor. Endocr Rev 1988; 9:106-121.
43. Smith BR, Sanders J, Furmaniak J. TSH receptor antibodies. Thyroid 2007; 17:923-938. (Pubitemid 350071602)
44. Arora P, Ricks TK, Trejo J. Protease-activated receptor signalling, endocytic sorting and dysregulation in cancer. J Cell Sci 2007; 120:921-928. (Pubitemid 46638507)
45. Schott M, Scherbaum WA, Morgenthaler NG. Thyrotropin receptor autoantibodies in Graves' disease. Trends Endocrinol Metab 2005; 16:243-248. (Pubitemid 40853888)
46. Sanders J, Chirgadze DY, Sanders P et al. Crystal structure of the TSH receptor in complex with a thyroid-stimulating autoantibody. Thyroid 2007; 17:395-410. (Pubitemid 46878842)
47. van Pel M, Hagoort H, Kwakkenbos MJ et al. Differential role of CD97 in interleukin-8-induced and granulocyte-colony stimulating factor-induced hematopoietic stem and progenitor cell mobilization. Haematologica 2008; 93:601-604. (Pubitemid 351536390)
48. Veninga H, Becker S, Hoek RM et al. Analysis of CD97 expression and manipulation: Antibody treatment but not gene targeting curtails granulocyte migration. J Immunol 2008; 181:6574-6583.
49. Yona S, Lin HH, Dri P et al. Ligation of the adhesion-GPCR EMR2 regulates human neutrophil function. FASEB J2008; 22:741-751. (Pubitemid 351348127)
50. Galle J, Sittig D, Hanisch I et al. Individual cell-based models of tumor-environment interactions: Multiple effects of CD97 on tumor invasion. Am J Pathol 2006; 169:1802-1811. (Pubitemid 351182009)
51. Shiratsuchi T, Futamura M, Oda K et al. Cloning and characterization of BAI-associated protein 1: A PDZ domain-containing protein that interacts with BAI1. Biochem Biophys Res Commun 1998; 247:597-604. (Pubitemid 28418437)
52. Yamamoto Y, Irie K, Asada M et al. Direct binding of the human homologue of the Drosophila disc large tumor suppressor gene to seven-pass transmembrane proteins, tumor endothelial marker 5 (TEM5) and a novel TEM5-like protein. Oncogene 2004; 23:3889-3897. (Pubitemid 38747917)